The number of people with susceptibility test result for rifampicin in Cuba
Cuba: The number of people with susceptibility test result for rifampicin was 133 in 2021. ▼ Falling
Latest (2021)
133
Change on year
down 30.0%
World rank
104th
of 155 countries
All-time high
340
in 2018
All-time low
133
in 2021
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Cuba, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Cuba recorded 133 for the number of people with susceptibility test result for rifampicin in 2021. That is the lowest value across all 5 years on record.
That represents a change of down 30.0% on the previous year and down 54.1% over five years.
Cuba ranks 104th of 155 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Cuba, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 290 | — |
| 2018 | 340 | +17.2% |
| 2019 | 319 | -6.2% |
| 2020 | 190 | -40.4% |
| 2021 | 133 | -30.0% |
Cuba compared with similar countries
- Cuba's 133 is below the median for upper middle income countries, which is 880, 15% of the median. (46 countries reporting)
- Cuba's 133 is below the median for Latin America & Caribbean, which is 406.5, 33% of the median. (26 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 316.33 | 290 | 340 | 3 |
| 2020s | 161.5 | 133 | 190 | 2 |
Countries ranked near Cuba
More health data for Cuba
- Un projection of annual infant deaths, annual growth rate -1.47 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.2059 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,696 deaths per 1,000 people (2090)
- Number of infants who die before age 1 67 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.62 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2020)
- Population ages 00-04, female, per capita 0.021 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.64 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2020)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Cuba?
- The number of people with susceptibility test result for rifampicin in Cuba was 133 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Cuba?
- The highest recorded value was 340 in 2018.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Cuba?
- The lowest recorded value was 133 in 2021.
- How does Cuba rank for the number of people with susceptibility test result for rifampicin?
- Cuba ranks 104th out of 155 countries with data for 2021.
- Where does this Cuba data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).